Biallelic CACNA1A variants: Review of literature and report of a child with drug-resistant epilepsy and developmental delay.
Vivien M Y Wong-SpracklenAnna KolesnikJosefine EckSaras SabanathanOlivera Spasic-BoskovicAnna MawKate BakerPublished in: American journal of medical genetics. Part A (2022)
Biallelic variants in CACNA1A have previously been reported in nine individuals (four families) presenting with epilepsy and cognitive impairments of variable severity and age-of-onset. Here, we describe a child who presented at 6 months of age with drug-resistant epilepsy and developmental delay. At 10 years of age, she has profound impairments in motor function and communication. MRI was initially unremarkable, but progressed to severe cerebellar atrophy by age 3 years. Next Generation Sequencing and panel analysis identified a maternally inherited truncating variant c.2042_2043delAG, p.(Gln681ArgfsTer100) and paternally inherited missense variant c.1693G>A, p.(Glu565Lys). In contrast to previously reported biallelic cases, parents carrying these monoallelic variants did not display clear signs of a CACNA1A-associated syndrome. In conclusion, we provide further evidence that biallelic CACNA1A variants can cause a severe epileptic and developmental encephalopathy with progressive cerebellar atrophy, and highlight complexities of genetic counseling in such situations.
Keyphrases
- drug resistant
- intellectual disability
- copy number
- multidrug resistant
- acinetobacter baumannii
- early onset
- autism spectrum disorder
- mental health
- magnetic resonance imaging
- genome wide
- contrast enhanced
- multiple sclerosis
- magnetic resonance
- human immunodeficiency virus
- hepatitis c virus
- temporal lobe epilepsy
- drug induced